Empagliflozin and cardiovascular and kidney outcomes across KDIGO risk categories: post hoc analysis of a randomized, double-blind, placebo-controlled, multinational trial
Eur J Heart Fail 22:19841986 Mizuno Y, Harada E, Nakagawa H, Morikawa Y, Shono M, Kugimiya F, Yoshimura M, Yasue H (2017) The diabetic heart utilizes ketone bodies as an energy source
The later activation was found to increase transcription of cortical and hippocampal BDNF and send molecular signals necessary for maintaining neuronal survival
Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus
However, supplementation should always be part of a broader, comprehensive management strategy that includes aggressive pacing, nervous system regulation, and targeted medical care
How much do GLP-1 pills cost, and will they be cheaper than injections